Reduced plasma desmosterol-to-cholesterol ratio and longitudinal cognitive decline in Alzheimer's disease

BACKGROUND: We here examined whether plasma desmosterol-to-cholesterol ratio (DES/CHO) is decreased in patients with Alzheimer's disease (AD) and investigated the association between plasma DES/CHO and longitudinal cognitive decline. METHODS: Plasma DES/CHO of AD patients and age-matched contro...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Yoshiaki, Bernier, Francois, Yamanaka, Yasukazu, Aoshima, Ken, Oda, Yoshiya, Ingelsson, Martin, Lannfelt, Lars, Miyashita, Akinori, Kuwano, Ryozo, Ikeuchi, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Blood-Based Biomarker
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876914/
https://www.ncbi.nlm.nih.gov/pubmed/27239493
http://dx.doi.org/10.1016/j.dadm.2014.11.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876914/
https://www.ncbi.nlm.nih.gov/pubmed/27239493
http://dx.doi.org/10.1016/j.dadm.2014.11.009

Ejemplares similares